Source: Virtual Congress 2021 – COVID - 19: lessons learned



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bielosludtseva (Dniepropetrovsk, Ukraine), K. Fugol (Dniepropetrovsk, Ukraine), M. Krykhtina (Dniepropetrovsk, Ukraine), O. Popova (Dniepropetrovsk, Ukraine). The best predictor of COVID-19 pneumonia progression during lung ultrasound (LUS). 514

Member's Comments

No comment yet.

Related content which might interest you: Negative predictive value of autofluorescence imaging (AFI) in patients at high risk for lung cancer Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007 The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer Source: Eur Respir J 2006; 28: 915-919 Year: 2006 CT densitometry as a predictor of pulmonary function in lung cancer patients Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease Year: 2011 CT scans from CF patients screened for lung transplant; the severe advanced lung disease (SALD) CT scoring system and correlation with survival Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007 Accuracy of the calculated estimated postoperative pulmonary function (CEPPF) in lung cancer patients Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007 Tumourinvasion or -impression? Endobronchial ultrasound (EBUS) allows differentiation in patients with lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 6s Year: 2001 Analyzing images of endobronchial ultrasonography (EBUS) using histogram to assist in the diagnosis of lung cancer Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012 Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer Year: 2007 A value of ultrasonographic predictors of malignancy in left adrenal gland in lung cancer patients – a comparison of EUS-b, CT and PET-CT Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021 Lung cancer in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 1216-1219 Year: 2001 CT quantification of lung lesions as a prognostic factor for severe lung damage in COVID-19 patients Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Prevalence of interstitial lung disease (ILD) in a lung cancer screening program using low-dose computer tomography (CT) Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease Year: 2011 Predictive factors of idiopathic pulmonary fibrosis (IPF) in patients with a possible or inconsistent with usual interstitial pneumonia (UIP) pattern on high resolution computed tomography (HRCT) Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 CT scanning is an imperfect means of predicting pathological stage in lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 82s Year: 2006 Why the fibrobronchoscopy (FB) and the CT-scan have the same importance for establishing the correct staging of lung carcinoma a 4 years study in a respiratory unit Source: Eur Respir J 2001; 18: Suppl. 33, 325s Year: 2001 Chartis evaluation of collateral ventilation versus HRCT assessment, in predicting clinical outcomes following endobronchial valve therapy (EBV) in COPD patients Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 Modelling the cancer risk potentially associated with repetitive CT scanning in cystic fibrosis Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 The clinical value of fluorescence bronchoscopy in predicting survivals in patients with small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 150s Year: 2006 The value of autofluorescence bronchoscopy in the pre-operative staging of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 525s Year: 2004